We are live on !
Find out more
Trium Capital Portfolio holdings
AUM
$79.4M
Turnover
54.79%
1-Year Est. Return
36.67%
This Fund
S&P 500
This Quarter Est. Return
+8.97%
1 Year Est. Return
+36.67%
3 Year Est. Return
+214.74%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$79.4M
AUM Growth
-$83.1M
(-51%)
Cap. Flow
-$71.8M
Cap. Flow % of AUM
Cap. Flow %
-90.31%
Top 10 Holdings %
Top 10 Hldgs %
82.01%
Holding
73
New
20
Increased
1
Reduced
32
Closed
20
Avg Time Held
Equity + Options
0.7
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.3
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Simulations Plus
SLP
|
+$12.4M |
| 2 |
Genco Shipping & Trading
GNK
|
+$4.55M |
| 3 |
Snowflake
SNOW
|
+$2.69M |
| 4 |
BioLife Solutions
BLFS
|
+$2.58M |
| 5 |
Middleby
MIDD
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Esperion Therapeutics
ESPR
|
+$35.3M |
| 2 |
AT&T
T
|
+$22.5M |
| 3 |
Sapiens International
SPNS
|
+$7.56M |
| 4 |
Alumis Inc
ALMS
|
+$3.92M |
| 5 |
Wabtec
WAB
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 40.47% |
| 2 | Healthcare | 21.82% |
| 3 | Industrials | 15.62% |
| 4 | Technology | 6.33% |
| 5 | Real Estate | 5.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
Excelerate Energy
EE
$1.01B
| $1.19K | ﹤0.01% |
37
-35
| -49% | -$1.32K |
2026 Q1
2 quarters
|
|
52
Banner Corp
BANR
$2.52B
| $268 | ﹤0.01% |
+4
| New | +$281 |
2026 Q3
0 quarters
|
|
53
Devon Energy
DVN
$53.8B
| $184 | ﹤0.01% |
4
-4
| -50% | -$184 |
2026 Q2
1 quarter
|
|
54
Acuity Brands
AYI
$9.46B
| – | – |
-1,152
| Closed | -$434K | – |
|
55
Dream Finders Homes
DFH
$879M
| – | – |
-2
| Closed | -$35 | – |
|
|
56
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-11,158,150
| Closed | -$35.3M | – |
|
57
Gorman-Rupp
GRC
$1.84B
| – | – |
-6,604
| Closed | -$606K | – |
|
58
Hudbay
HBM
$9.7B
| – | – |
-130
| Closed | -$3.07K | – |
|
59
Johnson Controls International
JCI
$87B
| – | – |
-10,196
| Closed | -$1.49M | – |
|
60
Linde
LIN
$233B
| – | – |
-4,066
| Closed | -$2.11M | – |
|
61
CALL
Strategy Inc
MSTR
$63.1B
| – | – |
-582,400
| Closed | -$256K | – |
|
62
Onto Innovation
ONTO
$9.9B
| – | – |
-600
| Closed | -$227K | – |
|
|
63
DELISTED
Sapiens International
SPNS
| – | – |
-173,884
| Closed | -$7.56M | – |
|
64
Shutterstock
SSTK
$172M
| – | – |
-62,086
| Closed | -$866K | – |
|
65
Tetra Tech
TTEK
$9.13B
| – | – |
-13,810
| Closed | -$399K | – |
|
66
Essential Utilities
WTRG
$12B
| – | – |
-44,644
| Closed | -$1.71M | – |
|
67
Watts Water Technologies
WTS
$11.7B
| – | – |
-406
| Closed | -$159K | – |
|
68
Weyerhaeuser
WY
$14.2B
| – | – |
-50,866
| Closed | -$1.22M | – |
|
69
QXO Inc
QXO
$11.4B
| – | – |
-70,478
| Closed | -$1.22M | – |
|
70
Smurfit Westrock
SW
$21.9B
| – | – |
-19,546
| Closed | -$904K | – |
|
71
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| – | – |
-384,252
| Closed | – | – |
|
|
ACHL
72
DELISTED
Achilles Therapeutics
ACHL
| – | – |
-61,506
| Closed | -$91K | – |
|
Similar funds
Trium Capital's Q3 2026 Portfolio in Review
As of Q3 2026, Trium Capital held 73 positions worth $79.4M, down 51% from $163M the previous quarter. Its ten largest holdings account for 82% of the portfolio.
Trium Capital withdrew a net $71.8M in Q3 2026, closing 20 positions and reducing 32 holdings. Its most notable exit was Esperion Therapeutics, an estimated $35.3M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 40% of assets, up from 36% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Trium Capital opened a new position in Simulations Plus worth $12.4M.
- Trium Capital's largest Q3 2026 buy was Simulations Plus: 673,172 shares worth $12.4M.
- Trium Capital added most to Shoals Technologies Group in Q3 2026, an estimated $72.2K increase.
- Trium Capital's biggest Q3 2026 reduction was AT&T, cutting an estimated $22.5M.
- Trium Capital fully exited Esperion Therapeutics in Q3 2026, selling an estimated $35.3M.
- Trium Capital's ten largest holdings make up 82% of its $79.4M portfolio in Q3 2026.
- Trium Capital opened 20 new positions and closed 20 in Q3 2026.
- Trium Capital's portfolio value fell 51% quarter-over-quarter to $79.4M.
Based on Trium Capital's 13F filing for Q3 2026, filed 16 Oct 2026.